Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Masaki Kato

Associate Professor

Kansai Medical University

Japan

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Psychiatry

100%

Clinical Psychology

50%

Major Depressive Disorder

100%

Geriatric Psychiatry

40%

Drug Repurposing

40%

Psychopathology

30%

Clinical Therapy

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles19

Practice Guidelines for Bipolar Disorder by the JSMD (Japanese Society of Mood Disorders)

Article Link

Year:

2024

Antidepressants available in Japan for older people with major depressive disorder: A systematic review and meta‐analysis

Article Link

Year:

2024

Comparison of brexpiprazole, aripiprazole, and placebo for Japanese major depressive disorder: A systematic review and network meta‐analysis

Article Link

Year:

2024

Adjunctive brexpiprazole 1 mg and 2 mg daily for Japanese patients with major depressive disorder following inadequate response to antidepressants: a phase 2/3, randomized, double‐blind (BLESS) study

Article Link

Year:

2024

Goal Attainment Scaling for Depression: Validation of the Japanese GAS-D Tool in Patients with Major Depressive Disorder

Article Link

Year:

2024

Association between treatment response and dose of blonanserin transdermal patch in patients with acute schizophrenia: A post hoc cluster analysis based on baseline psychiatric symptoms

Article Link

Year:

2024

Lithium-induced cognitive dysfunction assessed over 1-year hospitalisation: A case report

Article Link

Year:

2024

Costs of psychotropics for outpatients with bipolar disorder in Japan; the MUSUBI 2016 survey

Article Link

Year:

2023

Efficacy and safety of zuranolone in Japanese adults with major depressive disorder: A double‐blind, randomized, placebo‐controlled, phase 2 clinical trial

Article Link

Year:

2023

Newer antidepressant for Japanese adults with major depressive disorder: A systematic review and meta‐analysis

Article Link

Year:

2023

Changes in Multiple microRNA Levels with Antidepressant Treatment Are Associated with Remission and Interact with Key Pathways: A Comprehensive microRNA Analysis

Article Link

Year:

2023

The Burden of Attention-Deficit/Hyperactivity Disorder Traits in Adult Patients with Major Depressive Disorder in Japan

Article Link

Year:

2023

Appropriate duration of antidepressant medications for prevention of depressive relapse and the impact of life stage

Article Link

Year:

2023

Relapse and its modifiers in major depressive disorder after antidepressant discontinuation: meta-analysis and meta-regression

Article Link

Year:

2023

Assessing Reliability and Validity of the Oxford Depression Questionnaire (ODQ) in a Japanese Clinical Population

Article Link

Year:

2023

Characteristics of persistent depression in the long-term: Randomized controlled trial and two-year observational study

Article Link

Year:

2023

Mood Stabilizers and Antipsychotics for Acute Mania: Systematic Review and Meta-Analysis of Augmentation Therapy vs Monotherapy From the Perspective of Time to the Onset of Treatment Effects

Article Link

Year:

2022

Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission

Article Link

Year:

2022

Multiple Pre-Treatment miRNAs Levels in Untreated Major Depressive Disorder Patients Predict Early Response to Antidepressants and Interact with Key Pathways

Article Link

Year:

2022

Collaborators8

Yoshiteru Takekita

Associate Professor

Kansai Medical University

JAPAN

Hidetoshi Tahara

Hiroshima University

JAPAN

Nakao IWATA

Professor

Fujita Health University

JAPAN

YUKI ISOGAI

Cardiology, Medical Science / Section chief

Otsuka Pharmaceutical

JAPAN

Toshihiko Kinoshita

JAPAN

Nobuyuki Koga

Specially Appointed Associate Professor

Tokushima University

JAPAN

Aran Tajika

Kyoto University Hospital

JAPAN

Kiyotaka Nemoto

Associate Professor

University of Tsukuba

JAPAN

How do I reach out?

Meet Kite AI